| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| 3,7-Dibenzothiophenedicarboxaldehyde, 5,5-dioxide |
二苯并[B,D]噻吩-3,7-二甲醛5,5-二氧化物 |
82487-47-6 |
詳細
|
| 1,2,4,5-benzene tetracarboxalaldehyde |
1,2,4,5-苯四醛 |
14674-89-6 |
詳細
|
| 2-Propenamide, N-(cyanomethyl)- |
2-丙烯酰胺,N-(氰基甲基)- |
64186-79-4 |
詳細
|
| pyrazino[2,3-g]quinoxaline |
pyrazino[2,3-g]quinoxaline |
261-43-8 |
詳細
|
| 1,1'-Bis[3-(trimethylammonio)propyl]-4,4'-bipyridinium Tetrachloride Dihydrate |
1,1'-雙[3-(三甲基銨)丙基]-4,4'-聯(lián)吡啶四氯化物 二水合物 |
108228-37-1 |
詳細
|
| 10,12-HEPTACOSADIYNOIC ACID |
10,12-十七二炔酸 |
67071-94-7 |
詳細
|
| 2-(Diphenylphosphino)terephthalic acid |
2-(二苯基膦基)對苯二甲酸 |
1537175-69-1 |
詳細
|
| Benzaldehyde, 4,4',4''-[phosphinylidynetris(oxy)]tris- |
|
159213-46-4 |
詳細
|
| 5-Tetracenecarboxylic Acid |
并四苯-5-羧酸 |
858455-70-6 |
詳細
|
| 2-(oxolan-2-yl)acetic acid |
(四氫呋喃-2-基)乙酸 |
2434-00-6 |
詳細
|
| 2,3,5,6-Pyrazinetetracarboxylic acid |
|
49193-60-8 |
詳細
|
| JAB-3068 |
JAB-3068 |
2169223-48-5 |
詳細
|
| Fostemsavir |
福斯特沙韋 |
864953-29-7 |
詳細
|
| Temsavir |
1-(4-苯甲?；哙?1-基)-2-[4-甲氧基-7-(3-甲基-1H-1, 2, 4-三氮唑-1-基)-1H-吡咯并[2,3-C]吡啶-3-基)乙烷-1,2-二酮 |
701213-36-7 |
詳細
|
| JAB-3068 hydrochloride |
SHP2-IN-6 HYDROCHLORIDE |
2169223-49-6 |
詳細
|
| Fostemsavir Tris |
FOSTEMSAVIR TROMETHAMINE |
864953-39-9 |
詳細
|
| BMS-986142 |
BMS986142 |
1643368-58-4 |
詳細
|
| BMS-986205 |
BMS-986205 |
1923833-60-6 |
詳細
|
| Theliatinib tartrate |
XILIERTINIB TARTRATE|||HMPL-309 TARTRATE|||XILIERTINIB TARTRATE ; HMPL-309 TARTRATE |
2413487-72-4 |
詳細
|
| BMS-813160 |
CS-2742 |
1286279-29-5 |
詳細
|
| Rimegepant |
瑞美吉泮 |
1289023-67-1 |
詳細
|
| Theliatinib |
席栗替尼 |
1353644-70-8 |
詳細
|
| Sulfatinib |
5-羥基-2-甲基吲哚 |
1308672-74-3 |
詳細
|
| CPI-360 |
EZH2抑制劑(CPI-360) |
1802175-06-9 |
詳細
|
| CD-38 |
CD38 inhibitor |
1700637-55-3 |
詳細
|
| DTRIM24 |
dTRIM24 |
2170695-14-2 |
詳細
|
| LSY-05 |
Lys05 |
1391426-24-6 |
詳細
|
| Benzenamine, 2-(2-propenyl)- |
2-烯丙基苯胺 |
32704-22-6 |
詳細
|
| N-(4-bromophenyl)-N-di(4-pyridyl)amine |
N-(4-溴苯基)-N-(吡啶-4-基)吡啶-4-胺 |
1218812-58-8 |
詳細
|
| 3-Perylenecarboxaldehyde |
3-苝甲醛 |
35438-63-2 |
詳細
|
| 1-((tert-butoxycarbonyl)(Methyl)aMino)cyclopropanecarboxylic acid |
1-((叔丁氧羰基)(甲基)氨基)環(huán)丙烷-1-羧酸 |
119145-87-8 |
詳細
|
| SM-102 |
SM-102 |
2089251-47-6 |
詳細
|
| ALC-0159 |
甲氧基聚乙二醇雙十四烷基乙酰胺 |
1849616-42-7 |
詳細
|
| BMS-P5 |
BMS-P5 |
1550371-22-6 |
詳細
|
| ALC-0315 |
ALC-0315 |
2036272-55-4 |
詳細
|
| dBRD9 |
DBRD9 |
2170679-45-3 |
詳細
|
| GSK215 |
GSK215 |
2743427-26-9 |
詳細
|
| MRTX849 analog 24 |
4-[7-(8-CHLORO-1-NAPHTHALENYL)-5,6,7,8-TETRAHYDRO-2-[[(2S)-1-(4-PENTYN-1-YL)-2- |
2490716-96-4 |
詳細
|
| Nirogacestat |
PF-3084014 |
1290543-63-3 |
詳細
|
| ASTX-029 |
ASTX-029 |
2095719-92-7 |
詳細
|
| Nirogacestat dihydrobromide |
PF 3084014 HYDROBROMIDE |
1962925-29-6 |
詳細
|
| YF135 |
|
2913177-53-2 |
詳細
|
| MRTX849 acid |
MRTX849-溴丙酸衍生物 |
2561529-96-0 |
詳細
|
| MRTX849 ethoxypropanoic acid |
3-[3-[(2S)-2-[[[7-(8-CHLORO-1-NAPHTHALENYL)-4-[(3S)-3-(CYANOMETHYL)-4-(2-FLUORO- |
2561529-98-2 |
詳細
|
| CTP-354 |
CTP354 |
1213669-91-0 |
詳細
|
| (S)-Ceralasertib |
(S)-CERALASERTIB |
1352226-87-9 |
詳細
|
| AZD8186 |
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-嗎啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 |
1627494-13-6 |
詳細
|
| Lumacaftor |
魯瑪卡托 |
936727-05-8 |
詳細
|
| LC-2 |
PROTAC KRASG12C Degrader-LC-2 |
2502156-03-6 |
詳細
|
| Gusacitinib |
GUSACITINIB |
1425381-60-7 |
詳細
|
| Gusacitinib hydrochloride |
ASN-002_Hydrochloride |
2228989-14-6 |
詳細
|
| IA-14069 |
|
2271216-04-5 |
詳細
|
| Ulixertinib |
4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羥基乙基]-1H-吡咯-2-甲酰胺 |
869886-67-9 |
詳細
|
| Ulixertinib hydrochloride |
BVD-523 鹽酸鹽 |
1956366-10-1 |
詳細
|
| (R)-(+)-Etomoxir sodium salt |
(R)-(+)-乙莫克舍鈉鹽 |
828934-41-4 |
詳細
|
| HS-10296 |
阿美替尼 |
1899921-05-1 |
詳細
|
| GSK 2330672 |
GSK 2330672 |
1345982-69-5 |
詳細
|
| SB-431542 |
SB-431542 |
301836-41-9 |
詳細
|
| Zearalenone |
玉米烯酮 |
17924-92-4 |
詳細
|
| R-(+)-ETOMOXIR |
乙莫克舍 |
124083-20-1 |
詳細
|
| Omarigliptin (MK-3102) |
奧格列?。∕K-3102） |
1226781-44-7 |
詳細
|
| LX-4211 |
索格列凈 |
1018899-04-1 |
詳細
|
| Hyodeoxycholic acid |
豬去氧膽酸 |
83-49-8 |
詳細
|
| Canagliflozin |
卡格列凈 |
842133-18-0 |
詳細
|
| Doramapimod |
1-[2-(4-甲基苯基)-5-叔丁基吡唑-3-基]-3-[4-(2-嗎啉-4-基乙氧基)萘-1-基]脲 |
285983-48-4 |
詳細
|
| 3,4-Diaminofurazan |
3,4-二氨基呋扎 |
17220-38-1 |
詳細
|
| Bictegravir |
比克替拉韋 |
1611493-60-7 |
詳細
|
| 1,2,5-Oxadiazol-3-amine, 4,4'-(1,2,4-oxadiazole-3,5-diyl)bis- (9CI) |
1 |
405278-80-0 |
詳細
|
| Amphiregulin |
AMPHIREGULIN HUMAN RECOMBINANT |
117147-70-3 |
詳細
|
| Irinotecan Impurity 18 |
伊立替康雜質(zhì)18 |
1255644-71-3 |
詳細
|
| Nalfurafine N-Oxide |
Nalfurafine N-Oxide |
208042-42-6 |
詳細
|
| Talquetamab |
塔奎妥單抗 |
2226212-40-2 |
詳細
|
| Elranatamab |
埃納妥單抗 |
2408850-14-4 |
詳細
|
| (E)-N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide |
(E)-N-[(4R,4aS,7S,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-yl]-3-(furan-3-yl)-N-methylprop-2-enamide |
152658-36-1 |
詳細
|
| DescyclopropylMethyl Nalfurafine |
DescyclopropylMethyl Nalfurafine |
163713-06-2 |
詳細
|
| 1-Pentanone, 4-methyl-1-phenyl-2-(1-pyrrolidinyl)-, hydrochloride (1:1) |
N-[4-[[(3-甲氧基吡嗪基)氨基]磺?；鵠苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺 |
432531-71-0 |
詳細
|
| (3R,5R,6S)-Atogepant ((3R,5R,6S)-MK-8031) |
|
|
詳細
|
| 2H-1-Benzopyran-4-carboxamide, 7-bromo-3,4-dihydro-, (4R)- |
|
1851374-84-9 |
詳細
|
| TPPB |
TPPB |
497259-23-1 |
詳細
|
| Befiradol hydrochloride |
SYNONYMS: NLX-112 HYDROCHLORIDE; F 13640 HYDROCHLORIDE |
2436760-81-3 |
詳細
|
| BHS697 |
BHS697 |
943189-02-4 |
詳細
|
| befiradol |
貝非拉醇 |
208110-64-9 |
詳細
|
| MK-8031 |
阿托吉泮 |
1374248-81-3 |
詳細
|
| [3,3':4',3"-Tris(1,2,5-oxadiazole)]-4,4"-diamine |
[3,3':4',3"- 三(1,2,5- 惡二唑)]-4,4"-二胺 |
7741-27-6 |
詳細
|
| ADG 126 |
抗 Human CD152/CTLA4 (ADG 126) 單克隆抗體 |
|
詳細
|
| 5-Chloro-8-methyl-7-(3-methylbut-2-en-1-yl)-6,7,8,9-tetrahydro-2,7,9a-triazabenzo[cd]azulene-1(2H)-thione |
5-氯-8-甲基-7-(3-甲基丁-2-烯-1-基)-6,7,8,9-四氫-2,7,9a-三氮雜苯并[cd]薁-1(2H)-硫酮 |
257891-65-9 |
詳細
|
| SB 215505 |
6-氯-2,3-二氫-5-甲基-N-5-喹啉基-1H-吲哚-1-甲酰胺 |
162100-15-4 |
詳細
|
| CaproMorelin Tartrate |
卡普瑞林酒石酸鹽 |
193273-69-7 |
詳細
|
| Belotecan |
CKD-602 鹽酸鹽 |
213819-48-8 |
詳細
|
| Deruxtecan |
德魯替康 |
1599440-13-7 |
詳細
|
| Senexin B |
4-[[2-[6-[(4-甲基-1-哌嗪基)羰基]-2-萘基]乙基]氨基]-6-喹唑啉甲腈 |
1449228-40-3 |
詳細
|
| Navitoclax-piperazine |
ABT-263-piperazine |
2143096-93-7 |
詳細
|
| BPK29 |
BPK-29 |
2143467-62-1 |
詳細
|
| Desmorpholinyl Navitoclax-NH-Me |
化合物DESMORPHOLINYL NAVITOCLAX-NH-ME |
2365172-82-1 |
詳細
|
| NaV1.7 inhibitor-1 |
NaV1.7 inhibitor-1 |
1494585-79-3 |
詳細
|
| CHIKV-IN-2 |
5H-Benzocycloheptene-2-carboxamide, N-[4-(1-cyano-1-methylethyl)phenyl]-6,7,8,9-tetrahydro-3-methoxy- |
2361289-44-1 |
詳細
|
| NMDI14 |
NMDI14 |
307519-88-6 |
詳細
|
| A-385358 |
A-385358 |
406228-55-5 |
詳細
|
| SB-435495 |
SB-435495 |
304694-39-1 |
詳細
|
| Rilapladib |
瑞拉帕地 |
412950-08-4 |
詳細
|